| Rebecca Anne Noel, RN | |
|
2210 Kulshan View Dr Ste 105, Mount Vernon, WA 98273-2779 | |
| (425) 357-1790 | |
| Not Available |
| Full Name | Rebecca Anne Noel |
|---|---|
| Gender | Female |
| Speciality | Registered Nurse - Home Health |
| Location | 2210 Kulshan View Dr Ste 105, Mount Vernon, Washington |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1184488181 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 163W00000X | Registered Nurse | RN60136605 (Washington) | Secondary |
| 163WH0200X | Registered Nurse - Home Health | RN60136605 (Washington) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Rebecca Anne Noel, RN 1930 E Fir St, Mount Vernon, WA 98273-2634 Ph: (360) 927-2732 | Rebecca Anne Noel, RN 2210 Kulshan View Dr Ste 105, Mount Vernon, WA 98273-2779 Ph: (425) 357-1790 |
News Archive
Diabetic ketoacidosis (DKA), a life-threatening but preventable condition, remains an important problem for youth with diabetes and their families. Diabetic ketoacidosis is due to a severe lack of insulin and it is often the presenting symptom of type 1 diabetes. It can also be present at the onset of type 2 diabetes.
Synta Pharmaceuticals Corp. today announced that preclinical results presented at the "Bridging the Gap 2010" Hematologic Conference, held in Singapore City, Singapore, February 5-7, 2010, shows that STA-9090, a potent inhibitor of heat shock protein 90 (Hsp90), inhibits the Wilms' tumor 1 (WT1) protein, a key transcription factor that drives disease progression in acute myeloid leukemia (AML) as well as certain other leukemias. STA-9090 is currently enrolling patients in two clinical trials in AML and other hematologic cancers.
The European Commission (EC) has approved expanded options for pre-treatment prior to use of QUTENZA (8% capsaicin patch). Before application the patient may now take an oral analgesic, or the treatment area may be pre-treated with a topical anaesthetic.1 The 8% capsaicin patch is the first and only licensed high concentration (8%) capsaicin cutaneous patch for the treatment of peripheral neuropathic pain in Europe.
Researchers with Lawrence Berkeley National Laboratory (Berkeley Lab) and the University of California (UC) Berkeley have provided important new details into the activation of the epidermal growth factor receptor (EGFR), a cell surface protein that has been strongly linked to a large number of cancers and is a major target of cancer therapies.
› Verified 6 days ago
Ms. Jane E. Kaptein, RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 1401 S Laventure Rd, Mount Vernon, WA 98274 Phone: 206-424-2400 Fax: 206-424-2428 | |
Brian Francis, Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 209 Milwaukee St, Mount Vernon, WA 98273 Phone: 425-349-6200 | |
Mrs. Susan Walker Thomas, RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 20564 English Rd, Mount Vernon, WA 98274 Phone: 614-886-4583 | |
Elizabeth Irene Cooksey, BSN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 700 S 2nd St, Mount Vernon, WA 98273 Phone: 360-770-7743 | |
Lydia Anne Reading, RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 2324 Monica Dr, Mount Vernon, WA 98273 Phone: 360-424-5540 Fax: 360-424-5540 | |
Heidi Mitchell-sanchez, RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 700 S 2nd St Ste 301, Mount Vernon, WA 98273 Phone: 360-416-1517 Fax: 360-416-1501 |